SIRT3 overexpression promoted the phosphorylation status of JNK whereas it had no effect on total JNK expression in all three HCC cells (SMMC-7721, Huh-7 and PLC/PRF/5) treated with chemotherapeutic agents (Figure 5C–5E). This evidence concerns the gene SIRT3 and hepatocellular carcinoma.